CLINICAL_TRIALS
trial_result
· 2016-07-28
Clinical Trial Update: A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664) [Phase 3]
Summary
Phase 3 trial of preladenant in early Parkinson's disease was terminated; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Parkinson Disease | Phase 3 | Status: TERMINATED | Results posted: 2016-07-28